Precision Oncology: 2023 in Review

Area of Science:

• Oncology
• Genomics
• Clinical Pharmacology

Background:

• Precision oncology leverages molecular profiling to tailor cancer treatments.
• Significant progress has been made in identifying targetable mutations and developing corresponding therapies.

Approach:

• This review synthesizes recent advancements in precision oncology from late 2022 through 2023.
• It examines various classes of precision oncology drugs and their companion biomarkers.
• Improvements in clinical trial methodologies for efficient drug evaluation are discussed.

Key Points:

• Identification of novel drug classes and biomarkers driving precision oncology.
• Enhanced understanding of molecular mechanisms underlying cancer treatment response.
• Evolution of adaptive and biomarker-driven clinical trial designs.

Conclusions:

• Recent advances are rapidly expanding the scope and efficacy of precision oncology.
• Future implications include more personalized and effective cancer care strategies.
• Continued integration of biomarker discovery and innovative trial designs is crucial for future progress.